Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc. financial statements

Dianthus Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 2.04M10-K
Net income−USD 162.34M10-K
Cash and equivalentsUSD 51.09M10-Q
Total debtUSD 1.39MEODHD

Dianthus Therapeutics, Inc. financials on 6ix · Dianthus Therapeutics, Inc. on 6ix